Investigation of the Anticarcinogenic Effects of Hypericum perforatum Extract on Human Thyroid Cancer


Дәйексөз келтіру

Толық мәтін

Аннотация

Introduction/Objective:Plants and their bioactive compounds play a crucial role in the pharmaceutical industry for treating cancer. To date, the cytotoxic and antiproliferative effects of Hypericum perforatum methanol extract on human thyroid cancer cell lines have not been thoroughly explored. The present study aimed to assess the potential anti-cancer effects of HPME on human thyroid cancer and investigate its potential therapeutic benefits.

Methods:HPME was prepared using the maceration method, and its antioxidant activity was examined. Cytotoxicity studies were then carried out, followed by an investigation of the possible effects of HPME on metastasis and colony-forming capacities of human thyroid cancer cells. Afterward, qRT-PCR, western blotting, and apoptosis assays were performed.

Results:Cytotoxicity studies revealed notable cytotoxicity of HPME against the TT cell line. Moreover, HPME significantly curtailed metastasis and invasion of TT cells in an in vitro wound healing assay. Analyses of gene expressions demonstrated an elevation in caspase-12, caspase-3, and Bax, coupled with a reduction in BcL-2, APOE, and CLU expression. Following HPME treatment, there was an increase in the protein expression levels of Bax and Caspase-12, while a decrease in the BcL-2, APOE, and CLU protein expression. Furthermore, apoptotic studies indicated an increase in early apoptosis.

Conclusion:Overall results revealed that HPME demonstrates a notable antioxidant capacity in human thyroid cancer. It exerts an influence on crucial biological processes associated with cancer, indicating its potential to hinder the proliferation of human thyroid cancer cells by enhancing apoptosis through the upregulation of gene and protein expression, particularly involving caspases.

Авторлар туралы

Cigdem Gokcek-Sarac

Department of Biomedical Engineering, Faculty of Engineering, Akdeniz University

Email: info@benthamscience.net

Gizem Altunkaya

Department of Biochemistry, Faculty of Science, Selcuk University

Email: info@benthamscience.net

Serdar Karakurt

Department of Biochemistry, Faculty of Science, Selcuk University

Хат алмасуға жауапты Автор.
Email: info@benthamscience.net

Әдебиет тізімі

  1. Li, L.; Cheng, L.; Sa, R.; Qiu, X.; Chen, L. Real-world insights into the efficacy and safety of tyrosine kinase inhibitors against thyroid cancers. Crit. Rev. Oncol. Hematol., 2022, 172, 103624. doi: 10.1016/j.critrevonc.2022.103624 PMID: 35150866
  2. Sen, M.; Ito, R.; Abe, T.; Kazusaka, H.; Matsui, M.; Saitou, M.; Nagaoka, R.; Jikuzono, T.; Sugitani, I. Elevations of neutrophil-to-lymphocyte ratio and C-reactive protein over time as a precursor to anaplastic transformation of papillary thyroid carcinoma: a case report. Surg. Case Rep., 2024, 10(1), 190. doi: 10.1186/s40792-024-01991-x PMID: 39158760
  3. Nan, B.; Xiong, G.F.; Zhao, Z.R.; Gu, X.; Huang, X.S. Comprehensive identification of potential crucial genes and miRNA-mRNA regulatory networks in papillary thyroid cancer. BioMed Res. Int., 2021, 2021, 1-25. doi: 10.1155/2021/6752141 PMID: 33521130
  4. Lukyanov, S.A.; Titov, S.E.; Kozorezova, E.S.; Demenkov, P.S.; Veryaskina, Y.A.; Korotovskii, D.V.; Ilyina, T.E.; Vorobyev, S.L.; Zhivotov, V.A.; Bondarev, N.S.; Sleptsov, I.V.; Sergiyko, S.V. Prediction of the aggressive clinical course of papillary thyroid carcinoma based on fine needle aspiration biopsy molecular testing. Int. J. Mol. Sci., 2024, 25(13), 7090. doi: 10.3390/ijms25137090 PMID: 39000197
  5. Vander, H.M.G.; DeBerardinis, R.J. Understanding the intersections between metabolism and cancer biology. Cell, 2017, 168(4), 657-669. doi: 10.1016/j.cell.2016.12.039 PMID: 28187287
  6. Lin, X.; Zhang, J.; Zhao, R.H.; Zhang, W.J.; Wu, J.F.; Xue, G. APOE is a prognostic biomarker and correlates with immune infiltrates in papillary thyroid carcinoma. J. Cancer, 2022, 13(5), 1652-1663. doi: 10.7150/jca.63545 PMID: 35371313
  7. Ren, L.; Yi, J.; Li, W.; Zheng, X.; Liu, J.; Wang, J.; Du, G. Apolipoproteins and cancer. Cancer Med., 2019, 8(16), 7032-7043. doi: 10.1002/cam4.2587 PMID: 31573738
  8. Saetta, A.A.; Lazaris, A.C.; Miaouli, M.; Voutsinas, G.E.; Patsouris, E.; Tseleni-Balafouta, S. Resistance to fas-mediated apoptosis does not correlate to structural alterations or expression changes of the death receptor in papillary thyroid carcinomas. Pathobiology, 2018, 85(5-6), 304-310. doi: 10.1159/000492358 PMID: 30278467
  9. Batool, S.; Asim, L.; Raffaq, Q.F.; Masood, A.; Mushtaq, M.; Saleem, R.S.Z. Molecular targets of plant-based alkaloids and polyphenolics in liver and breast cancer- An insight into anticancer drug development. Anticancer. Agents Med. Chem., 2024, 24 doi: 10.2174/0118715206302216240628072554 PMID: 38963106
  10. Koralahalli, KP; Hussain, S; D, DW; Siddikuzzaman, V MB Molecular actions of enicostemma hyssopifolium whole plant extract on HPV18-infected human cervical cancer (HeLa) cells. Anticancer Agents Med Chem., 2024.
  11. Caldeira, G.I.; Gouveia, L.P.; Serrano, R.; Silva, O.D. Hypericum genus as a natural source for biologically active compounds. Plants, 2022, 11(19), 2509. doi: 10.3390/plants11192509 PMID: 36235373
  12. Avila, C.; Whitten, D.; Evans, S. The safety of St John’s wort ( Hypericum perforatum ) in pregnancy and lactation: A systematic review of rodent studies. Phytother. Res., 2018, 32(8), 1488-1500. doi: 10.1002/ptr.6099 PMID: 29708295
  13. Rizzo, P.; Altschmied, L.; Ravindran, B.M.; Rutten, T.; D’Auria, J.C. The biochemical and genetic basis for the biosynthesis of bioactive compounds in Hypericum perforatum L., one of the largest medicinal crops in Europe. Genes (Basel), 2020, 11(10), 1210. doi: 10.3390/genes11101210 PMID: 33081197
  14. Matic, I.Z.; Ergün, S.; Crnogorac, M.D.; Misir, S.; Aliyazicioglu, Y.; Damjanovic, A. Cytotoxic activities of L. extracts against 2D and 3D cancer cell models. Cytotechnology, 2021, 73(3), 373-389. doi: 10.1007/s10616-021-00464-5 PMID: 34149173
  15. Agapouda, A.; Booker, A.; Kiss, T.; Hohmann, J.; Heinrich, M.; Csupor, D. Quality control of Hypericum perforatum L. analytical challenges and recent progress. J. Pharm. Pharmacol., 2018, 71(1), 15-37. doi: 10.1111/jphp.12711 PMID: 28266019
  16. Sarrou, E.; Giassafaki, L.P.; Masuero, D.; Perenzoni, D.; Vizirianakis, I.S.; Irakli, M. Metabolomics assisted fingerprint of chemotypes and assessment of their cytotoxic activity. Food Chem. Toxicol., 2018, 114, 325-333. doi: 10.1016/j.fct.2018.02.057 PMID: 29499307
  17. Rizzo, P.; Altschmied, L.; Ravindran, B.M.; Rutten, T.; D’Auria, J.C. The biochemical and genetic basis for the biosynthesis of bioactive compounds in L., one of the largest medicinal crops in Europe. Genes (Basel), 2020, 11(10) doi: 10.3390/genes11101210 PMID: 33081197
  18. Şebin, M.; Yılmaz, N.; Aydın, A. Some wild mushrooms with high antioxidant capacity exhibit potent anticancer activity on cancer cells using the apoptotic and antimigration cell death mechanisms. Anticancer. Agents Med. Chem., 2023, 23(13), 1567-1576. doi: 10.2174/1871520623666230331084010 PMID: 37005536
  19. Apak, R.; Güçlü, K.; Özyürek, M.; Karademir, S.E. Novel total antioxidant capacity index for dietary polyphenols and vitamins C and E, using their cupric ion reducing capability in the presence of neocuproine: CUPRAC method. J. Agric. Food Chem., 2004, 52(26), 7970-7981. doi: 10.1021/jf048741x PMID: 15612784
  20. Pargi, M.; Raviraj, S.K.J.; Narayanappa, P.; Urumarudappa, S.K.J.; Malleshappa, P.; Malleshappa, K.H. Antiproliferative effects of fruit extract and its bioactive fraction through upregulation of p53/γH2AX signals and G2/M phase arrest in MIA PaCa-2 cells. Anti-Cancer Agent Me., 2022, 22(17), 2998-3008. doi: 10.2174/1871520622666220201103431 PMID: 35105296
  21. Kandir, S.; Karakurt, S.; Gökçek-Saraç, Ç.; Karakurt, S. Tannic acid elicits differential gene regulation in prostate cancer apoptosis. Acta Pharm., 2024, 74(3), 539-550. doi: 10.2478/acph-2024-0020 PMID: 39279521
  22. Chen, X.; Li, Z.; Yi, X.; Jin, C. Lidocaine inhibits the lung cancer progression through decreasing the HIST1H2BL levels via SIRT5 mediated succinylation. Sci. Rep., 2024, 14(1), 23310. doi: 10.1038/s41598-024-73966-9 PMID: 39375419
  23. Karakurt, S.; Abuşoğlu, G.; Arituluk, Z.C. Comparison of anticarcinogenic properties of Viburnum opulus and its active compound p-coumaric acid on human colorectal carcinoma. Turk. J. Biol., 2020, 44(5), 252-263. doi: 10.3906/biy-2002-30 PMID: 33110363
  24. Celik, G.; Semiz, A.; Karakurt, S.; Gencler-Ozkan, A.M.; Arslan, S.; Adali, O.; Sen, A. Inhibitory action of Epilobium hirsutum extract and its constituent ellagic acid on drug-metabolizing enzymes. Eur. J. Drug Metab. Pharmacokinet., 2016, 41(2), 109-116. doi: 10.1007/s13318-014-0238-1 PMID: 25425117
  25. Celik-Turgut, G.; Olmez, N.; Koc, T.; Ozgun-Acar, O.; Semiz, A.; Dodurga, Y.; Lale Satiroglu-Tufan, N.; Sen, A. Role of AHR, NF-kB and CYP1A1 crosstalk with the X protein of Hepatitis B virus in hepatocellular carcinoma cells. Gene, 2023, 853, 147099. doi: 10.1016/j.gene.2022.147099 PMID: 36476661
  26. Liang, S.; Jin, J.; Shen, X.; Jiang, X.; Li, Y.; He, Q. Triptolide protects podocytes via autophagy in immunoglobulin A nephropathy. Exp. Ther. Med., 2018, 16(3), 2275-2280. doi: 10.3892/etm.2018.6480 PMID: 30186468
  27. Filetti, S.; Durante, C.; Hartl, D.; Leboulleux, S.; Locati, L.D.; Newbold, K.; Papotti, M.G.; Berruti, A. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 2019, 30(12), 1856-1883. doi: 10.1093/annonc/mdz400 PMID: 31549998
  28. Hostanska, K.; Reichling, J.; Bommer, S.; Weber, M.; Saller, R. Hyperforin a constituent of St John’s wort (L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines. Eur. J. Pharm. Biopharm., 2003, 56(1), 121-132. doi: 10.1016/S0939-6411(03)00046-8 PMID: 12837490
  29. Eghdami, A.; Piri, H.; Sirati-Sabet, M.; Ilghari, D. Investigation of anti proliferative properties and antioxidant activity of aerial parts ethanolic extract of Hypericum perforatum L. by breast cancer 4T1 cell lines. Int. J. Biosci., 2013, 3(12), 265-272. doi: 10.12692/ijb/3.12.265-272
  30. Seyrekoğlu, F.; Temiz, H. Effect of Extraction Conditions on the Phenolic Content and DPPH Radical Scavenging Activity of Hypericum perforatum L. Turkish J. Agriculture - Food Sci. Technol., 2020, 8(1), 226-229. doi: 10.24925/turjaf.v8i1.226-229.3013
  31. Sarikurkcu, C.; Locatelli, M.; Tartaglia, A.; Ferrone, V.; Juszczak, A.M.; Ozer, M.S.; Tepe, B.; Tomczyk, M. Enzyme and biological activities of the water extracts from the plants Aesculus hippocastanum, Olea europaea and Hypericum perforatum that are used as folk remedies in Turkey. Molecules, 2020, 25(5), 1202. doi: 10.3390/molecules25051202 PMID: 32155959
  32. Eroglu, E.; Girgin, S.N. A unique phenolic extraction method from olive oil macerate of using DMSO: Assessment of anticancer activity, LC-MS/MS profile, total phenolic content and antioxidant capacity. S. Afr. J. Bot., 2021, 139, 6-11. doi: 10.1016/j.sajb.2021.01.015
  33. Mojic, M.; Pristov, J.B.; Maksimovic-Ivanic, D.; Jones, D.R.; Stanic, M.; Mijatovic, S. Extracellular iron diminishes anticancer effects of vitamin C: An study; Sci Rep-Uk, 2014, p. 4.
  34. Ryszawy, D.; Pudełek, M.; Catapano, J.; Ciarach, M.; Setkowicz, Z.; Konduracka, E.; Madeja, Z.; Czyż, J. High doses of sodium ascorbate interfere with the expansion of glioblastoma multiforme cells in vitro and in vivo. Life Sci., 2019, 232, 116657. doi: 10.1016/j.lfs.2019.116657 PMID: 31306660
  35. Gönenç, T.M.; Ozturk, M.; Türkseven, S.G.; Kirmizibayrak, P.B.; Günal, S.; Yilmaz, S. Hypericum perforatum L.: An overview of the anticancer potencies of the specimens collected from different ecological environments. Pak. J. Bot., 2020, 52(3), 1003-1010. doi: 10.30848/PJB2020-3(24)
  36. Onder, T.T.; Gupta, P.B.; Mani, S.A.; Yang, J.; Lander, E.S.; Weinberg, R.A. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res., 2008, 68(10), 3645-3654. doi: 10.1158/0008-5472.CAN-07-2938 PMID: 18483246
  37. Fuzio, P.; Napoli, A.; Ciampolillo, A.; Lattarulo, S.; Pezzolla, A.; Nuzziello, N.; Liuni, S.; Giorgino, F.; Maiorano, E.; Perlino, E. Clusterin transcript variants expression in thyroid tumor: a potential marker of malignancy? BMC Cancer, 2015, 15(1), 349. doi: 10.1186/s12885-015-1348-0 PMID: 25934174
  38. Arora, C.; Kaur, D.; Naorem, L.D.; Raghava, G.P.S. Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway. PLoS One, 2021, 16(11), e0259534. doi: 10.1371/journal.pone.0259534 PMID: 34767591
  39. Wang, Y.; Yu, H.; Zhang, J.; Gao, J.; Ge, X.; Lou, G. Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest. BMC Cancer, 2015, 15(1), 682. doi: 10.1186/s12885-015-1706-y PMID: 26459308
  40. Zhao, Z.; Zou, S.; Guan, X.; Wang, M.; Jiang, Z.; Liu, Z.; Li, C.; Lin, H.; Liu, X.; Yang, R.; Gao, Y.; Wang, X. Apolipoprotein E overexpression is associated with tumor progression and poor survival in colorectal cancer. Front. Genet., 2018, 9, 650. doi: 10.3389/fgene.2018.00650 PMID: 30631342
  41. Ito, Y.; Takano, T.; Miyauchi, A. Apolipoprotein e expression in anaplastic thyroid carcinoma. Oncology, 2006, 71(5-6), 388-393. doi: 10.1159/000107112 PMID: 17690558
  42. Celık, E. Apoptotic and anti-inflammatory effects of hypericum perforatum extract in human basal cell carcinoma TE 354.T cell line. Dicle Tip Derg., 2021, 48(1), 92-98. doi: 10.5798/dicletip.887378

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bentham Science Publishers, 2025